Mohan Brahmandam

2.4k total citations
30 papers, 1.9k citations indexed

About

Mohan Brahmandam is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Hematology. According to data from OpenAlex, Mohan Brahmandam has authored 30 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Hematology. Recurrent topics in Mohan Brahmandam's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mohan Brahmandam is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Multiple Myeloma Research and Treatments (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Mohan Brahmandam collaborates with scholars based in United States and Japan. Mohan Brahmandam's co-authors include Charles S. Fuchs, Shuji Ogino, Takako Kawasaki, Massimo Loda, Gregory J. Kirkner, Kenneth C. Anderson, Teru Hideshima, Dharminder Chauhan, Klaus Podar and Nikhil C. Munshi and has published in prestigious journals such as Blood, Cancer Cell and Oncogene.

In The Last Decade

Mohan Brahmandam

25 papers receiving 1.9k citations

Peers

Mohan Brahmandam
S Dirnhofer Switzerland
Christopher C. Porter United States
Jin Sung Jang United States
Kunihiko Takeyama United States
Mohan Brahmandam
Citations per year, relative to Mohan Brahmandam Mohan Brahmandam (= 1×) peers Gerwin Heller

Countries citing papers authored by Mohan Brahmandam

Since Specialization
Citations

This map shows the geographic impact of Mohan Brahmandam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohan Brahmandam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohan Brahmandam more than expected).

Fields of papers citing papers by Mohan Brahmandam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohan Brahmandam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohan Brahmandam. The network helps show where Mohan Brahmandam may publish in the future.

Co-authorship network of co-authors of Mohan Brahmandam

This figure shows the co-authorship network connecting the top 25 collaborators of Mohan Brahmandam. A scholar is included among the top collaborators of Mohan Brahmandam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohan Brahmandam. Mohan Brahmandam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Greenfield, Edward, James A. DeCaprio, & Mohan Brahmandam. (2021). Making Weak Antigens Strong: Preparing Immune Complexes for Injection. Cold Spring Harbor Protocols. 2021(9). pdb.prot099978–pdb.prot099978. 1 indexed citations
2.
Greenfield, Edward, James A. DeCaprio, & Mohan Brahmandam. (2020). Preparing GST-, His-, or MBP-Fusion Proteins from Bacteria. Cold Spring Harbor Protocols. 2020(9). pdb.prot100024–pdb.prot100024. 9 indexed citations
3.
Greenfield, Edward, James A. DeCaprio, & Mohan Brahmandam. (2019). Transfected Dendritic Cell Immunizations. Cold Spring Harbor Protocols. 2019(3). pdb.prot100073–pdb.prot100073. 3 indexed citations
4.
Greenfield, Edward, James A. DeCaprio, & Mohan Brahmandam. (2019). Detecting Protein Antigens in Sodium Dodecyl Sulfate-Polyacrylamide Gels. Cold Spring Harbor Protocols. 2019(12). pdb.prot099994–pdb.prot099994. 3 indexed citations
5.
Greenfield, Edward, James A. DeCaprio, & Mohan Brahmandam. (2018). Making Weak Antigens Strong: Modifying Protein Antigens by Denaturation. Cold Spring Harbor Protocols. 2018(5). pdb.prot099960–pdb.prot099960. 5 indexed citations
6.
Greenfield, Edward, James A. DeCaprio, & Mohan Brahmandam. (2018). Making Weak Antigens Strong: Cross-Linking Peptides to KLH with Maleimide. Cold Spring Harbor Protocols. 2018(10). pdb.prot100016–pdb.prot100016. 7 indexed citations
7.
Jones, Robert T., Malak Abedalthagafi, Mohan Brahmandam, et al.. (2014). Cross-reactivity of the BRAF VE1 antibody with epitopes in axonemal dyneins leads to staining of cilia. Modern Pathology. 28(4). 596–606. 45 indexed citations
8.
Morikawa, Teppei, Kaori Shima, Aya Kuchiba, et al.. (2012). No Evidence for Interference of H&E Staining in DNA Testing. American Journal of Clinical Pathology. 138(1). 122–129. 29 indexed citations
9.
Chauhan, Dharminder, Ajita Singh, Mohan Brahmandam, et al.. (2009). Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target. Cancer Cell. 16(4). 309–323. 213 indexed citations
10.
Chauhan, Dharminder, Ajita Singh, Mohan Brahmandam, et al.. (2008). Combination of a Novel Proteasome Inhibitor NPI-0052 and Lenalidomide Trigger in Vivo Synergistic Cytotoxicity in Multiple Myeloma. Blood. 112(11). 3662–3662. 4 indexed citations
11.
Chauhan, Dharminder, Ajita Singh, Mohan Brahmandam, et al.. (2007). Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma. Blood. 111(3). 1654–1664. 160 indexed citations
12.
Chauhan, Dharminder, Mohan Brahmandam, Ajita Singh, et al.. (2007). Plasmacytoid Dendritic Cells Induce Growth and Survival of Multiple Myeloma Cells: Therapeutic Application.. Blood. 110(11). 3507–3507. 1 indexed citations
13.
Ogino, Shuji, Takako Kawasaki, Mohan Brahmandam, et al.. (2006). Precision and Performance Characteristics of Bisulfite Conversion and Real-Time PCR (MethyLight) for Quantitative DNA Methylation Analysis. Journal of Molecular Diagnostics. 8(2). 209–217. 336 indexed citations
14.
Ogino, Shuji, Mohan Brahmandam, Takako Kawasaki, et al.. (2006). Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis. Modern Pathology. 19(8). 1083–1090. 36 indexed citations
15.
16.
Chauhan, Dharminder, Mugdha Velankar, Mohan Brahmandam, et al.. (2006). A novel Bcl-2/Bcl-XL/Bcl-w inhibitor ABT-737 as therapy in multiple myeloma. Oncogene. 26(16). 2374–2380. 183 indexed citations
17.
Ogino, Shuji, Robert D. Odze, Takako Kawasaki, et al.. (2006). Correlation of Pathologic Features With CpG Island Methylator Phenotype (CIMP) by Quantitative DNA Methylation Analysis in Colorectal Carcinoma. The American Journal of Surgical Pathology. 30(9). 1175–1183. 81 indexed citations
18.
Ogino, Shuji, Mohan Brahmandam, Takako Kawasaki, et al.. (2005). Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Modern Pathology. 19(1). 59–68. 206 indexed citations
19.
Ogino, Shuji, Takako Kawasaki, Mohan Brahmandam, et al.. (2005). Sensitive Sequencing Method for KRAS Mutation Detection by Pyrosequencing. Journal of Molecular Diagnostics. 7(3). 413–421. 402 indexed citations
20.
Ogino, Shuji, Jeffrey A. Meyerhardt, Mohan Brahmandam, et al.. (2005). Molecular Alterations in Tumors and Response to Combination Chemotherapy with Gefitinib for Advanced Colorectal Cancer. Clinical Cancer Research. 11(18). 6650–6656. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026